River Global Investors LLP Decreases Stock Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

River Global Investors LLP reduced its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 26.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 29,327 shares of the company's stock after selling 10,754 shares during the period. River Global Investors LLP's holdings in Bath & Body Works were worth $1,137,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Golden State Wealth Management LLC purchased a new stake in Bath & Body Works during the fourth quarter valued at approximately $26,000. SRS Capital Advisors Inc. increased its position in shares of Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock worth $26,000 after purchasing an additional 329 shares in the last quarter. True Wealth Design LLC lifted its holdings in shares of Bath & Body Works by 5,270.0% during the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company's stock valued at $34,000 after purchasing an additional 1,054 shares during the last quarter. UMB Bank n.a. boosted its position in shares of Bath & Body Works by 58.8% in the 4th quarter. UMB Bank n.a. now owns 905 shares of the company's stock worth $35,000 after purchasing an additional 335 shares in the last quarter. Finally, Lindbrook Capital LLC grew its stake in Bath & Body Works by 81.9% during the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock worth $37,000 after buying an additional 431 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company's stock.

Remove Ads

Bath & Body Works Stock Performance

Bath & Body Works stock traded down $0.51 during midday trading on Wednesday, hitting $29.29. 4,806,856 shares of the company were exchanged, compared to its average volume of 4,054,065. The business has a fifty day simple moving average of $36.91 and a two-hundred day simple moving average of $34.10. The firm has a market capitalization of $6.34 billion, a PE ratio of 7.14, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89. Bath & Body Works, Inc. has a fifty-two week low of $26.20 and a fifty-two week high of $52.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported $2.09 EPS for the quarter, topping analysts' consensus estimates of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $2.79 billion for the quarter, compared to analysts' expectations of $2.78 billion. As a group, equities analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works declared that its Board of Directors has authorized a stock buyback plan on Thursday, February 27th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to reacquire up to 6.4% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's leadership believes its shares are undervalued.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were given a $0.20 dividend. The ex-dividend date of this dividend was Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.73%. Bath & Body Works's dividend payout ratio (DPR) is currently 21.98%.

Analyst Upgrades and Downgrades

A number of research firms have commented on BBWI. TD Cowen increased their price target on Bath & Body Works from $42.00 to $48.00 and gave the company a "buy" rating in a research note on Thursday, December 12th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Bath & Body Works from $51.00 to $52.00 and gave the company a "buy" rating in a research report on Tuesday, November 26th. Cowen reissued a "buy" rating on shares of Bath & Body Works in a research report on Thursday, February 27th. Raymond James restated an "outperform" rating and set a $46.00 price target (up previously from $42.00) on shares of Bath & Body Works in a research note on Tuesday, February 25th. Finally, Morgan Stanley dropped their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating on the stock in a report on Thursday, November 21st. Five investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $45.06.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.